USA Pharma is a renowned biopharmaceutical firm which is focused on oncology and rare disease. The firm recently made headlines following the appointment of its leadership team. This saw the appointment of Caster Thiel as President in Europe.
The appointment also saw Darell Cohen land the head of clinical development. The move is seen to strengthen the leadership at the pharmaceutical firm with the new appointees each having extensive experience in the field. Caster Thiel will be in charge of the growth of the commercial infrastructure based in Europe and across the world.
Caster Thiel has a broad portfolio including close to three decades of commercial experience to EUSA. This has made him gain various international roles in the biopharmaceutical field. Recently, Caster Thiel was the CEO of Abeona Therapeutics firm based in the US with specialization in gene therapy.
In addition, Caster Thiel also served for a couple of years as the Chief Commercial Officer based at the Alexion Pharmaceuticals. He spearheaded the firm’s EMEA, Australasia, and Asia Pacific organizations.
Before landing the role as head of Europeat Amgen, he controlled the firms’ European oncology franchise. At the beginning of his career, he served in the pharmaceutical industry based at Hoffman La-Roche.
Caster Thiel is a holder of a Ph.D. in Molecular Biology and Biochemistry from Germany.
As the former GM of Insadong East Europe, Caster Thiel was in charge of the launch of various successful pharma products. It is through his extensive industrial experience that he has managed to launch successful product launches.
Caster Thiel has an intense devotion towards the strong ethics and belief of humanity at the workplace. He was proven beyond doubt through his leadership skills as a front runner in the pharmaceutical industry.
Visit Caster LinkedIn : https://ch.linkedin.com/in/carsten-thiel-8970b45